|Publication number||USD561907 S1|
|Application number||US 29/265,237|
|Publication date||Feb 12, 2008|
|Filing date||Aug 28, 2006|
|Priority date||Jan 27, 2004|
|Also published as||USD527463, USD585561, USD607118, USD623764|
|Publication number||265237, 29265237, US D561907 S1, US D561907S1, US-S1-D561907, USD561907 S1, USD561907S1|
|Inventors||Daniel Py, Norbert M. Assion, Julian V. Chan|
|Original Assignee||Medical Instill Technologies, Inc.|
|Export Citation||BiBTeX, EndNote, RefMan|
|External Links: USPTO, USPTO Assignment, Espacenet|
The broken lines in the figures show structure or boundaries that are not part of the claimed design, but rather show the environment in which the design is associated, or show portions of the article in which the design is embodied or applied to that are not considered part of the claimed design.
The shading and tones, and any variations thereof, shown in the informal drawings do not imply any specific colors or color contrast scheme in the article to be patented. In addition, the surface coloration and tones, and the variations thereof, shown in the informal drawings form no part of the claimed design.
The diagonal lines (or shading lines) are intended to show that the respective portion(s) of the vial are transparent or substantially transparent, whereas the claimed portion(s) of the vial that do not include such lines are opaque or substantially opaque.